TL1A Archives - Medical Conferences

RELIEVE-UCCD: Good results for TL1A inhibitor duvakitug in UC

Presented By

Prof. Walter Reinisch, Medical University of Vienna, Austria

Trial

Phase 2, RELIEVE-UCCD

Conference

DDW 2025

Type

News article

21 May 2025 12:35

TL1A-LTB axis induces perianal fistulising disease-associated changes in CD

Presented By

Dr Victoria Gudino, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Spain

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 11:31

Novel TL1A inhibitor achieves high rates at stringent endpoints in UC

Presented By

Prof. Vipul Jairath, Western University, Canada

Trial

Phase 2, TUSCANY-2

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:57

Positive results for TL1A inhibitor duvakitug in CD

Presented By

Prof. Vipul Jairath, Western University, Canada

Trial

Phase 2, RELIEVE UCCD

Conference

ECCO 2025

Type

Peer-reviewed article

8 April 2025 10:52

TL1A inhibitor tulisokibart shows potential in UC

Presented By

Dr Christopher Ma, University of Calgary, Canada

Trial

Phase 2, ARTEMIS-UC

Conference

UEGW 2024

Type

Peer-reviewed article

28 November 2024 11:21

ARTEMIS-UC: New kid in town for UC

Presented By

Prof. Bruce Sands, Icahn School of Medicine at Mount Sinai, USA

Trial

Phase 2, ARTEMIS-UC

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:20